These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16408376)

  • 1. High-dose chemotherapy for advanced breast cancer.
    Ahmad K
    Lancet Oncol; 2006 Jan; 7(1):19. PubMed ID: 16408376
    [No Abstract]   [Full Text] [Related]  

  • 2. High dose chemotherapy for breast cancer: taking stock.
    O'Shaughnessy J
    Oncologist; 2000; 5(1):14-7. PubMed ID: 10706644
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose intensity in chemotherapy of metastatic breast cancer.
    J Clin Oncol; 1985 Jun; 3(6):889-91. PubMed ID: 3891924
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group.
    Colleoni M; Price K; Castiglione-Gertsch M; Goldhirsch A; Coates A; Lindtner J; Collins J; Gelber RD; Thürlimann B; Rudenstam CM
    Eur J Cancer; 1998 Oct; 34(11):1693-700. PubMed ID: 9893654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy for breast cancer.
    Nieto Y; Shpall EJ
    Cancer Treat Res; 2000; 103():77-114. PubMed ID: 10948443
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose chemotherapy for breast cancer: is another look warranted?
    Nieto Y; Jones RB; Shpall EJ
    Curr Opin Oncol; 2004 Mar; 16(2):114-9. PubMed ID: 15075901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving treatment approaches for early breast cancer.
    Campos SM
    Breast Cancer Res Treat; 2005; 89 Suppl 1():S1-7. PubMed ID: 15770534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy for breast cancer: we have not heard the final word.
    Bearman SI
    Cancer Invest; 2000; 18(5):494-7. PubMed ID: 10834035
    [No Abstract]   [Full Text] [Related]  

  • 9. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
    Tamura K
    Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
    [No Abstract]   [Full Text] [Related]  

  • 10. [High dose chemotherapy in treatment of breast carcinoma: current status and limits of this method of therapy].
    Derigs HG; Huber C; Mahlke M; Kolbe K
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):190-7. PubMed ID: 8682284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.
    Bar MH
    Conn Med; 2000 Jan; 64(1):3-6. PubMed ID: 10697358
    [No Abstract]   [Full Text] [Related]  

  • 12. Mastectomy followed by cytoreductive chemotherapy in locally advanced breast cancer.
    Pluzańska A; Berner J; Dowgier-Witczak I; Malecka E; Pawlowski R; Wrezel E; Jeziorski A; Kamińska A; Tenderenda M
    J Chemother; 1989 Jul; 1(4 Suppl):1186-8. PubMed ID: 16312827
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day].
    Bonneterre J; Coppens H; Mauriac L; Rouesse J; Fargeot P; Metz R; Armand JP; Mathieu A; Tubiana M; Cappelaere P
    Acta Clin Belg Suppl; 1986; 11():41-8. PubMed ID: 3521171
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancer.
    Hryniuk WM; Levine MN; Levin L
    NCI Monogr; 1986; (1):87-94. PubMed ID: 3534595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy for breast cancer: evolving data.
    Antman K; Tiersten A
    Oncology (Williston Park); 1999 Sep; 13(9):1215-9. PubMed ID: 10509318
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in the hormonal treatment of breast cancer.
    Boughey JC; Buzdar AU; Hunt KK
    Curr Probl Surg; 2008 Jan; 45(1):13-55. PubMed ID: 18206436
    [No Abstract]   [Full Text] [Related]  

  • 17. Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?
    Esteva FJ; Hortobagyi GN
    J Natl Cancer Inst; 2008 Apr; 100(8):521-3. PubMed ID: 18398093
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
    Howell A; Rubens RD; Bush H; George WD; Howat JM; Crowther D; Sellwood RA; Hayward JL; Knight RK; Bulbrook RD
    Recent Results Cancer Res; 1984; 96():74-89. PubMed ID: 6396780
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of dose in the treatment of breast cancer.
    Gianni L; Mariani G; Mariani P
    Ann Oncol; 2004; 15 Suppl 4():iv31-5. PubMed ID: 15477328
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.
    Hurvitz SA; Andre F; Jiang Z; Shao Z; Mano MS; Neciosup SP; Tseng LM; Zhang Q; Shen K; Liu D; Dreosti LM; Burris HA; Toi M; Buyse ME; Cabaribere D; Lindsay MA; Rao S; Pacaud LB; Taran T; Slamon D
    Lancet Oncol; 2015 Jul; 16(7):816-29. PubMed ID: 26092818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.